Skip to content
The Surprise Ledger
What treatment costs here, and who is actually paying.

The Surprise Ledger

What do people ask about PRP, the blood-based shot?

A sore joint can turn a simple choice into a tiresome one. You need straight answers about the bill, the visits, and what relief is uncertain. Start with the question that matters most to you, then read its answer below.

Is PRP covered by insurance?

A PRP shot uses a portion of your blood that holds many platelets. Medicare's written policy doesn't cover it for joint soreness, while other plans use their own rules. Call your insurer, ask about platelet-rich plasma by name, and request the answer in writing.

How much does PRP therapy cost in Surprise or the West Valley?

There isn't a published national price that settles a local charge. Ask for one total covering the exam, treatment, ultrasound guidance, and later checks. Two prices can only be compared when they include the same care.

How much do 3 sessions of PRP cost?

The number of treatments and the price differ among clinics. Don't compare the total for three treatments with a price for one visit. Ask why three are advised, what's included, and whether care stops when the first treatment doesn't help.

Is PRP worth the money?

It may be worth asking about after exercise, medicine, braces, or physical therapy haven't helped enough. PRP can't promise relief, and you'll commonly pay the whole bill. Compare that cost with the daily tasks you hope to regain.

How many PRP treatments are needed?

There isn't one settled number for every joint. Ask how many visits are planned and what the clinic advises when the first treatment brings no relief. You'll hear that answer before agreeing to more care.

Does PRP work for people over 65?

Age alone doesn't show whether PRP is a sensible choice. Your daily limits, earlier care, exam, and X-ray matter too. At QC Kinetix, medical providers can review those details and explain their concentrated PRP treatment during a consultation.

Sources

  1. Medicare's national coverage policy covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and only within an approved coverage-with-evidence-development clinical study. There is no Medicare national coverage for PRP in osteoarthritis or tendinopathy, which is why these injections are billed to the patient as cash-pay.

    Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2024.

  2. The ESSKA-ICRS consensus applied the RAND/UCLA appropriateness method to 216 clinical scenarios for intra-articular PRP in knee OA. Only 84 scenarios (38.9%) were rated appropriate, 9 (4.2%) inappropriate and 123 (56.9%) uncertain. PRP was judged appropriate in patients aged 80 or under with KL grade 0-III osteoarthritis AFTER failed conservative non-injective or injective treatment; it was NOT considered appropriate as a first treatment, nor in KL grade IV (bone-on-bone) osteoarthritis, where 91.7% and 87.5% of scenarios respectively were uncertain.

    Kon E, de Girolamo L, Laver L, et al. — Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surgery, Sports Traumatology, Arthroscopy, 2024. DOI: 10.1002/ksa.12320.

  3. A meta-analysis of 73 articles covering 5,895 patients quantified the PLACEBO response to intra-articular injection in knee osteoarthritis: statistically and clinically significant improvements in pain, function and quality of life at 1, 3 and 6 months, with responder rates above 50% at each of those points, declining by 12 months. The placebo response was stronger in trials with more female participants and in more recently published trials. This is why an uncontrolled 'our patients improved' figure carries almost no information.

    Previtali D, Boffa A, Di Laura Frattura G, et al. — Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression. EFORT Open Reviews, 2025. DOI: 10.1530/EOR-2025-0022.

  4. The Cochrane review of STEM CELL injections for knee osteoarthritis concluded that on low-certainty evidence they may slightly improve pain and function, with uncertainty about effects on quality of life, treatment success and structural progression, and uncertainty about safety. This matters on a PRP site because 'stem cell therapy' is routinely used as a marketing label for PRP; they are different products with different evidence and PRP must never be described as a stem cell treatment.

    Whittle SL, Johnston RV, McDonald S, et al. — Stem cell injections for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2025. DOI: 10.1002/14651858.CD013342.pub2.

Would an exam help you decide?

An exam can show whether the soreness comes from the joint or nearby tissue. QC Kinetix can then explain its concentrated PRP treatment and give you a current price. Take your X-ray, medicine names, and questions so the visit stays useful.

Book a free consultation